医学理论与实践
醫學理論與實踐
의학이론여실천
The Journal of Medical Theory and Practice
2014年
14期
1827-1828,1831
,共3页
异环磷酰胺%紫杉醇%小细胞肺癌%化疗
異環燐酰胺%紫杉醇%小細胞肺癌%化療
이배린선알%자삼순%소세포폐암%화료
Ifosfamide%Taxol%Refractory small cell lung cancer%Chemotherapy
目的:观察异环磷酰胺(IFO )、紫杉醇(T AX )联合化疗治疗难治型小细胞肺癌的疗效及毒副反应。方法:32例难治型小细胞肺癌采用IFO 2.0静滴连用4d ,美司钠(MESNA)400mg于IFO 后0、4、8h静脉输注,TAX 150mg/m2第1天静脉输注。21d为1个周期。化疗2个周期评价疗效和毒副反应。结果:总有效率40.6%(13/32),疾病控制率68.8%(22/32),中位生存时间7.1个月。主要毒副反应为骨髓抑制。结论:以异环磷酰胺、紫杉醇联合化疗治疗小细胞肺癌能有效地提高患者近期疗效,毒副反应能够耐受。
目的:觀察異環燐酰胺(IFO )、紫杉醇(T AX )聯閤化療治療難治型小細胞肺癌的療效及毒副反應。方法:32例難治型小細胞肺癌採用IFO 2.0靜滴連用4d ,美司鈉(MESNA)400mg于IFO 後0、4、8h靜脈輸註,TAX 150mg/m2第1天靜脈輸註。21d為1箇週期。化療2箇週期評價療效和毒副反應。結果:總有效率40.6%(13/32),疾病控製率68.8%(22/32),中位生存時間7.1箇月。主要毒副反應為骨髓抑製。結論:以異環燐酰胺、紫杉醇聯閤化療治療小細胞肺癌能有效地提高患者近期療效,毒副反應能夠耐受。
목적:관찰이배린선알(IFO )、자삼순(T AX )연합화료치료난치형소세포폐암적료효급독부반응。방법:32례난치형소세포폐암채용IFO 2.0정적련용4d ,미사납(MESNA)400mg우IFO 후0、4、8h정맥수주,TAX 150mg/m2제1천정맥수주。21d위1개주기。화료2개주기평개료효화독부반응。결과:총유효솔40.6%(13/32),질병공제솔68.8%(22/32),중위생존시간7.1개월。주요독부반응위골수억제。결론:이이배린선알、자삼순연합화료치료소세포폐암능유효지제고환자근기료효,독부반응능구내수。
Objective :To investigate the efficiency and toxicities of ifosfamide with taxol as the second line chemothera-py in the treatment of refractory small cell lung cancer (SCLC) .Methods :Thirty-two patients with refractory small cell lung cancer were received the chemotherapy :Ifosfamide 2 .0 d1~4 ,Mesna 400mg 0 ,4 ,8hours after ifosfamide ;taxol 150mg/m2 ,every 21 days was 1 cycle .The efficiency and toxicities were evaluated after 2 cycles of chemotherapy .Re-sults:The response rate was 40 .6% (13/32) ,disease control rate was 68 .8% (22/32) ,the median survival was 7 .1 months ,the main toxicity was myelosuppression .Conclusion:Ifosfamide combined with taxol as the second line chemo-therapy is effective in the treatment of refractory small cell lung cancer (SCLC) ,and the toxicities are mild .